Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Cancer Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

March 2010
1. FADERL S , Ferrajoli A, Wierda W, O'Brien S, et al
   Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. JABBOUR E , Thomas D, Cortes J, Kantarjian HM, et al
   Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. WRIGHT JD , St Clair CM, Deutsch I, Burke WM, et al
   Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SAMPAT K , Rossi A, Garcia-Gutierrez V, Cortes J, et al
   Characteristics of pericardial effusions in patients with leukemia.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
5. KAY NE , Wu W, Kabat B, Laplant B, et al
   Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. RIGOLIN GM , Maffei R, Rizzotto L, Ciccone M, et al
   Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ZENT CS , Laplant BR, Johnston PB, Call TG, et al
   The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
8. KANTARJIAN HM , Cortes J, La Rosee P, Hochhaus A, et al
   Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. FADERL S , O'Brien S, Pui CH, Stock W, et al
   Adult acute lymphoblastic leukemia: concepts and strategies.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. PRINTZ C
    CancerScope. Janet Rowley, MD, continues to explore genetic causes of leukemia.
    Cancer. 2010;116:261-2.
    PubMed     Text format     Related articles   
    
    
    
11. TARRAND JJ , Keating MJ, Tsimberidou AM, O'Brien S, et al
    Epstein-barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MCCLEARY NJ , Niedzwiecki D, Hollis D, Saltz LB, et al
    Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
13. LADAS EJ , Kroll DJ, Oberlies NH, Cheng B, et al
    A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL).
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
14. DIMOV ND , Medeiros LJ, Kantarjian HM, Cortes JE, et al
    Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. WU S , Fischer L, Gokbuget N, Schwartz S, et al
    Expression of interleukin 15 in primary adult acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. PORKKA K , Khoury HJ, Paquette RL, Matloub Y, et al
    Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. INABA H , Stewart CF, Crews KR, Yang S, et al
    Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
18. RAMSINGH G , Mehan P, Luo J, Vij R, et al
    Primary plasma cell leukemia: a Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. AL AMERI A , Koller C, Kantarjian H, Ravandi F, et al
    Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. CREWS KR , Zhou Y, Pauley JL, Howard SC, et al
    Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
21. RAVANDI F , Issa JP, Garcia-Manero G, O'Brien S, et al
    Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. QUINTAS-CARDAMA A , Kantarjian H, Cortes J
    Homoharringtonine, omacetaxine mepesuccinate, and chronic myeloid leukemia circa 2009.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TEFFERI A , Thiele J, Vardiman JW
    The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.
    Cancer. 2009;115:3842-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
24. THOMAS DA , Kantarjian HM, Stock W, Heffner LT, et al
    Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. CHEN W , Konoplev S, Medeiros LJ, Koeppen H, et al
    Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
26. JAIN N , Wierda W, Ferrajoli A, Wong F, et al
    A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. THOMAS IH , Ness KK, Gurney JG
    Reply to Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. HOGLER W , Shaw N
    Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. KONOPLEV S , Huang X, Drabkin HA, Koeppen H, et al
    Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
30. KANTARJIAN H , Pasquini R, Levy V, Jootar S, et al
    Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. MOTTA M , Wierda WG, Ferrajoli A
    Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. JAIN N , Brouwers P, Okcu MF, Cirino PT, et al
    Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. JAIN N , Reuben JM, Kantarjian H, Li C, et al
    Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a Phase 2 Trial.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. RENNEVILLE A , Boissel N, Zurawski V, Llopis L, et al
    Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a Study From the Acute Leukemia French Association.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. QUINTAS-CARDAMA A , De Souza Santos FP, Kantarjian H, O'Brien S, et al
    Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. ALVARADO Y , Kantarjian H, O'Brien S, Faderl S, et al
    Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. RIZZIERI DA , O'Brien JA, Broadwater G, Decastro CM, et al
    Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ALIBHAI SM , Leach M, Minden MD, Brandwein J, et al
    Outcomes and quality of care in acute myeloid leukemia over 40 years.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. LORENZI M , McMillan AJ, Siegel LS, Zumbo BD, et al
    Educational outcomes among survivors of childhood cancer in British Columbia, Canada: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) Program.
    Cancer. 2009;115:2234-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. BORTHAKUR G , Lin E, Jain N, Estey EE, et al
    Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
41. QUINTAS-CARDAMA A , Cortes JE, O'Brien S, Ravandi F, et al
    Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. TSIMBERIDOU AM , Keating MJ
    Treatment of fludarabine-refractory chronic lymphocytic leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. KHOURY HJ , Guilhot F, Hughes TP, Kim DW, et al
    Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.
    Cancer. 2009;115:1381-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
44. HARB AJ , Tan W, Wilding GE, Ford L, et al
    Treating octogenarian and nonagenarian acute myeloid leukemia patients-Predictive prognostic models.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. GARG R , Kantarjian H, Thomas D, Faderl S, et al
    Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherap
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. QUINTAS-CARDAMA A , Kantarjian H, Ravandi F, O'Brien S, et al
    Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
47. JABBOUR E , Giralt S, Kantarjian H, Garcia-Manero G, et al
    Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. KALAYCIO M
    Bendamustine: a new look at an old drug.
    Cancer. 2009;115:473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
49. PASKETT E , Herndon J 2nd, Donohue K, Naughton M, et al
    Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SUNG L , Gamis A, Alonzo TA, Buxton A, et al
    Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KATZ ML , Donohue KA, Alfano CM, Day JM, et al
    Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer: cancer and Leukemia Group B 79804.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
52. LEE S , Kim YJ, Chung NG, Lim J, et al
    The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. KANTARJIAN HM , Larson RA, Guilhot F, O'Brien SG, et al
    Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. TSIMBERIDOU AM , Tam C, Abruzzo LV, O'Brien S, et al
    Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. VERMA D , O'Brien S, Thomas D, Faderl S, et al
    Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. SHANAFELT TD , Jenkins G, Call TG, Zent CS, et al
    Validation of a new prognostic index for patients with chronic lymphocytic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HIJIYA N , Ness KK, Ribeiro RC, Hudson MM, et al
    Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
58. ROBAK T , Blonski JZ, Wawrzyniak E, Gora-Tybor J, et al
    Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report From the Polish Adult Leukemia Group.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. GRINBLATT DL , Yu D, Hars V, Vardiman JW, et al
    Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803).
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. KELLY WK , Halabi S, Elfiky A, Ou SS, et al
    Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer : results of Cancer and Leukemia Group B 99811.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
61. BORTHAKUR G , Kantarjian H, Wang X, Plunkett WK Jr, et al
    Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. THOMAS IH , Donohue JE, Ness KK, Dengel DR, et al
    Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. O'BRIEN S , Thomas D, Ravandi F, Faderl S, et al
    Outcome of adults with acute lymphocytic leukemia after second salvage therapy.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
64. ROBOZ GJ , Ritchie EK, Curcio T, Provenzano J, et al
    Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. KANTARJIAN H , O'Brien S, Cortes J, Wierda W, et al
    Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.
    Cancer. 2008;113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. MORIMOTO A , Imamura T, Ishii R, Nakabayashi Y, et al
    Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Cancer. 2008;113:1362-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. KANTARJIAN H , O'Brien S, Ravandi F, Cortes J, et al
    Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
    Cancer. 2008;113:1351-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. MUSTO P , Ferrara F
    Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    August 2008
69. ZENT CS , Call TG, Shanafelt TD, Tschumper RC, et al
    Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. FADERL S , Ferrajoli A, Wierda W, Huang X, et al
    Clofarabine combinations as acute myeloid leukemia salvage therapy.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. RAZA A , Mehdi M, Mumtaz M, Ali F, et al
    Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. O'BRIEN S , Thomas DA, Ravandi F, Faderl S, et al
    Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. TSIMBERIDOU AM , Estey E, Wen S, Pierce S, et al
    The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. CARAWAY NP , Thomas E, Khanna A, Payne L, et al
    Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: